Wethersfield, CT, United States of America

John Neilan

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: The Government of the United States of America, as Represented by the Secretary of Homeland Security, Genvec, Inc.. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Neilan. Retrieved from https://idiyas.com/inventor/john-neilan-irsxah07

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Washington, DC (US) (2018)
  • Wethersfield, CT (US) (2012 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor John Neilan: Advancements in Foot-and-Mouth Disease Research

Introduction

John Neilan, an accomplished inventor based in Wethersfield, Connecticut, has made significant contributions to the field of virology. With a total of five patents to his name, Neilan has developed innovative solutions aimed at combating foot-and-mouth disease (FMD), a viral disease that affects livestock.

Latest Patents

Among Neilan's latest patents is a noteworthy innovation involving the modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptides. This patent focuses on an isolated polynucleotide encoding a modified picornavirus 3C protease, which features an altered secondary structure and various amino acid substitutions. This modification enhances transgene expression of the P1 precursor polypeptide when transformed and co-expressed in a host cell, compared to the traditional picornavirus 3C protease.

Another significant patent is the minicircle DNA vector vaccine platform for foot-and-mouth disease. This invention utilizes minicircle DNA vectors for vaccination purposes. The transgene expression cassette embedded within these vectors includes critical components such as a eukaryotic translation initiation nucleotide sequence and a mutant nucleotide sequence that encodes an FMDV capsid polyprotein precursor. The minicircle DNA vectors can be transfected directly into the mammalian host's cells, allowing for the production of virus-like particles that stimulate the immune system to build adaptive immunity against foot-and-mouth disease.

Career Highlights

Throughout his career, John Neilan has worked with notable organizations, including the Government of the United States of America, represented by the Secretary of Homeland Security, and GenVec, Inc. His work in these respected institutions has further solidified his reputation as an innovative scientist dedicated to advancing medical research.

Collaborations

Neilan’s collaborations have been instrumental in his research endeavors. He has worked alongside talented individuals such as Michael Puckette and Max Rasmussen, contributing to successful projects that have pushed the boundaries of current virology and vaccine development.

Conclusion

John Neilan’s dedication to innovation in the field of virology has led to significant advancements in the fight against foot-and-mouth disease. With his extensive patents, collaborative spirit, and impactful career, he continues to be an influential figure in medical research and development. His contributions not only enhance understanding of infectious diseases but also pave the way for more effective vaccination strategies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…